Breast cancer is a multifactorial disease with an inherited predisposition being implicated in around 5% of all cases. Using previous epidemiological data assessing risks for the relatives ofwomen with breast cancer, we have identified 154 women (from a screened population of 35 505) cancer patients and 1558 age matched controls, showed that the relative risk (RR) of breast cancer increases for women over 55 years with a positive family history. The RR is 1 8 if only one relative is affected, 3-3 ifmore than one first degree relative is affected, and 2-3 if bilateral disease is present. In addition, in the families with a dominantly inherited predisposition to breast cancer, heterogeneity in the age of onset of cancer has been observed and women over the age of 50 from these families remain at increased risk compared with the general population.9"-Breast screening was introduced in the UK in 1986 with women between 50 and 64 invited every three years for either one or two view mammography.' Randomised controlled trials have shown that screening can reduce mortality by up to 30% in this age group.' It is recognised that the total numbers of cancers diagnosed can be increased if the frequency of screening is less than three years, although the cost per case will be proportionally higher.' Most European countries with population screening have introduced two yearly screening programmes. Targeting more frequent screening to women identified to be at high risk because of a hereditary predisposition is a rational method of using the available resources, although it is accepted that no trial has shown the mortality benefit of this approach.
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Here we present the results of a descriptive, pragmatic study to identify the number of women in the breast screening population at greater than twice the age related risk of developing breast cancer and assessment of the uptake of genetic counselling by those women considered to be at increased risk.
Methods
Women attending for breast screening were asked by the radiographer if they had a family history of breast cancer and the answers were recorded. The radiologist reviewed the information and those women with a family history fulfilling the following criteria were recalled to the breast screening centre by letter, which explained that their mammogram was normal and that the reason for recall was their family history.
The criteria used were the following:
(1) First degree relative with bilateral breast cancer. ofthis. Other at risk or affected family members were identified and contacted where appropriate by the consultand. In families with a possible dominantly inherited risk, the mode of inheritance of the predisposition was discussed. In the families with a predisposition to ovarian cancer, screening and prophylactic surgery was also discussed.
Results
In the three year period from October 1990 to September 1993, 35 505 women were screened at the North East Scotland breast screening centre, representing a 80-9% uptake for breast screening.'3 Of the screened population, 316 (0 89%) women were considered by the radiologists to fulfil the criteria for being at increased risk (figure). Fourteen women did not attend the radiology review appointment and 14 women declined the offer to be counselled at the genetic clinic.
A further 41 women did not attend the genetic clinic appointment. One had reported a first degree relative with bilateral breast cancer, five had reported having two or more first degree relatives with breast cancer, 23 had a first degree relative under 40 with breast cancer, and 12 were referred because of a family history suspicious of a dominantly inherited predisposition to cancer.
Of the women identified by the radiologists to be at increased risk, 247 (78%) attended the genetic clinic (table 1) . Of these, 26 women reported a first degree relative with bilateral breast cancer, 61 women reported two first degree relatives with breast cancer, 92 women reported a first degree relative under 40 years with breast cancer, two reported a male relative with breast cancer, and 66 women reported a family history suspicious of a dominantly inherited predisposition to cancer.
Following risk assessment, 93 (37%) women were found to be at less than twice the age related risk of breast cancer. Seventy-four of these women had a first degree relative under 40 years with breast cancer; the remaining women's family history was refuted following Sixty-three (26%) of the women seen at the genetic clinic were from families where there was an apparently dominantly inherited risk for breast and other cancers with three or more relatives affected over at least two generations. Thirty-nine of these women had reported a family history suspicious of a dominantly inherited predisposition and this was confirmed following verification of the diagnoses after attendance at the genetic clinic. Additional family history information was also identified to categorise the remaining 14 The third subject reported a history of breast and renal carcinoma in her mother, colon cancer in four maternal uncles, and ovarian carcinoma in her niece aged 35. She presented aged 63 with disseminated intra-abdominal carcinoma with a probable primary in her stomach. In addition, she had an ovarian mass which may have been metastatic or a primary tumour, but it was not investigated further. She died aged 63 from disseminated carcinomatosis.
The fourth woman reported a family history of two sisters aged 37 and 45 with unilateral breast carcinoma. She presented at the age of 64 with a unilateral, invasive ductal carcinoma at screening mammography. Discussion This is the first attempt (in the UK) at a population based study to assess the incidence of familial breast cancer and offer genetic counselling and more frequent mammography for those at greater than twice the age related risk of breast cancer. It shows that a small but significant number of women in the breast screening population between 50 and 64 years report a family history suspicious ofan inherited predisposition to cancer and which significantly increases the risk of breast cancer to them or their family members.
Identifying high risk women at attendance at the NHSBSP has several advantages. Most cancer family clinics offer their services to the women who seek their help but are unable to offer equity of access for genetic counselling and screening for other families at risk. As older women with better information about the family history are approached, more extensive pedigree information becomes available, making risk assessment easier. In the families with a high risk of premenopausal breast cancer, the first contact is with the women who have a low remaining lifetime risk and who are able to discuss the issue with the younger family members. As the mortality benefits of mammography in the 50 to 65 age group have been shown, the targeting ofmore frequent screening to the high risk women in the NHSBSP is a rational use of resources.
The major disadvantage of this approach is the risk of causing increased anxiety in the women. Our study initially requested information from the women about their family history. In our experience, most women are aware of the inherited predisposition to breast cancer and, as a result, are unlikely to be distressed by the request of family history information regarding cancer. The subsequent steps were guided by the women who were at liberty to decline further contact. We accept that further work is required to assess the effects fully (psychological sequelae, risk perception, modification of behaviour, and the likelihood and repercussions ofinformation dissemination within the family) of offering genetic counselling to the women in this study. Evans et al, '4 in a study to identify the risk perceptions of women attending a cancer genetic clinic, found that only 11% estimated their risk accurately and 41% underestimated their risk. They suggested that the women who underestimated their risk were likely to be worried by assessments of higher risk. In contrast, Lerman et all5 in a randomised, prospective trial of individualised breast cancer risk counselling versus general health counselling, offered to a cohort of women with one or more first degree relatives affected with breast cancer, found that the women offered specific breast cancer risk information were more likely to estimate their risk correctly. Their work also indicated that, in both groups, around two thirds ofthe women continued to overestimate their lifetime risk substantially, in spite of counselling. They raise the concern that the exaggerated risk perception in these women may reduce adherence to mammography guidelines,'6 lead to avoidance of breast self examination,'7 and impact adversely on quality of life.'8 They also raise concerns about the risk of inappropriate decision making by women (for example, request for prophylactic mastectomy) who falsely perceive their risks to be increased. These authors found that the women with increased levels of anxiety are least likely to improve their personal risk estimation, and their work indicates the need for further research in this area. We accept that our intervention may have caused similar worries to the subjects in this study and investigations are under way to assess this further. Many women seen in the present study have considered their family history to confer an increased risk to themselves and welcomed the opportunity to discuss this.
Among the high penetrance breast cancer predisposing genes that have been identified is the BRCA1 gene on chromosome 1 7q, implicated in breast and epithelial ovarian cancer and a proportion of early onset breast cancer families."' Another gene, termed BRCA2, has now been linked to a locus on chromosome 13,20 and 
